Pros and Cons of Endoscopic Procedures for Obesity

Sunday, October 15

3:45 PM - 4:05 PM

Location: Valencia Ballroom BC (Level 4)

Category: Obesity

Speaker(s)

Mark Topazian, MD, FACG

Professor of Medicine
Mayo Clinic
Rochester, Minnesota

Learning Objectives:

Assess the benefits and risks of endoscopic bariatric procedures.

456 Views

ViewAttendees 9 Take Notes

Favorite
0 Like
Tweet

Mark D. Topazian

Professor of Medicine
Mayo Clinic
Rochester, Minnesota

Dr. Mark Topazian is a Professor of Medicine, Mayo Clinic, and Consultant, Division of Gastroenterology and Hepatology at Haverford College, Haverford, PA He received his MD from Yale University, New Haven, CT. In addition to being a practicing gastroenterologist and therapeutic GI endoscopist at Mayo Clinic, he is an experienced clinical researcher, and currently serves a co-PI of an NIDDK/NCI-sponsored U01 consortium investigating the nexus of pancreatitis, diabetes, and pancreatic cancer. He has carried out an NIH-sponsored clinical trial of an endoscopic intervention for obesity, and been co-investigator in multicenter collaborative studies of pancreatic cancer screening in high-risk individuals. In his clinical practice he treats patients with pancreatic masses, pancreatic cysts, known or suspected pancreatitis, IPMN, as well as well persons seeking screening for pancreatic cancer. Dr. Topazian's research interests include diagnosis of early chronic pancreatitis utilizing biomarkers in pancreatic juice, and endoscopic ultrasound (EUS) in the evaluation and management of pancreatic disease.

Presentation(s):

Pros and Cons of Endoscopic Procedures for Obesity
Sunday, October 15
3:45 PM – 4:05 PM
Symposium F: Management of Obesity: Role of the Gastroenterologist
Sunday, October 15
3:45 PM – 5:00 PM

456 Views

ViewAttendees 9 Take Notes

Send Email for Mark Topazian

To

Subject

Body

<h1>  shared a speaker with you!</h1><div><b>Name:</b> Mark Topazian</div><div><b>Organization:</b> Mayo Clinic</div><div><b>Position:</b> Professor of Medicine</div><div><b>Bio:</b> Dr. Mark Topazian is a Professor of Medicine, Mayo Clinic, and Consultant, Division of Gastroenterology and Hepatology at Haverford College, Haverford, PA He received his MD from Yale University, New Haven, CT. In addition to being a practicing gastroenterologist and therapeutic GI endoscopist at Mayo Clinic, he is an experienced clinical researcher, and currently serves a co-PI of an NIDDK/NCI-sponsored U01 consortium investigating the nexus of pancreatitis, diabetes, and pancreatic cancer. He has carried out an NIH-sponsored clinical trial of an endoscopic intervention for obesity, and been co-investigator in multicenter collaborative studies of pancreatic cancer screening in high-risk individuals. In his clinical practice he treats patients with pancreatic masses, pancreatic cysts, known or suspected pancreatitis, IPMN, as well as well persons seeking screening for pancreatic cancer. Dr. Topazian's research interests include diagnosis of early chronic pancreatitis utilizing biomarkers in pancreatic juice, and endoscopic ultrasound (EUS) in the evaluation and management of pancreatic disease.</div>

Assets